Research ArticleArticle
Validation of the Toronto Psoriatic Arthritis Screen Version 2 (ToPAS 2)
Brian D.M. Tom, Vinod Chandran, Vernon T. Farewell, Cheryl F. Rosen and Dafna D. Gladman
The Journal of Rheumatology May 2015, 42 (5) 841-846; DOI: https://doi.org/10.3899/jrheum.140857
Brian D.M. Tom
From the MRC Biostatistics Unit, UK Institute of Public Health, Cambridge, UK; the Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital; Division of Dermatology, Toronto Western Hospital, University of Toronto, Toronto, Ontario,
Canada.
Vinod Chandran
Vernon T. Farewell
Cheryl F. Rosen
Dafna D. Gladman
REFERENCES
- 1.↵
- 2.↵
- Gladman DD,
- Schentag CT,
- Tom BD,
- Chandran V,
- Brockbank J,
- Rosen CF,
- et al.
- 3.↵
- Gladman DD
- 4.↵
- Gladman DD,
- Thavaneswaran A,
- Chandran V,
- Cook RJ
- 5.↵
- Haroon M,
- Gallagher P,
- Fitzgerald O
- 6.↵
- 7.↵
- Tinazzi I,
- Adami S,
- Zanolin EM,
- Caimmi C,
- Confente S,
- Girolomoni G,
- et al.
- 8.↵
- 9.↵
- Walsh JA,
- Callis DK,
- Krueger GG,
- Clegg DO
- 10.↵
- Haroon M,
- Kirby B,
- Fitzgerald O
In this issue
The Journal of Rheumatology
Vol. 42, Issue 5
1 May 2015
Validation of the Toronto Psoriatic Arthritis Screen Version 2 (ToPAS 2)
Brian D.M. Tom, Vinod Chandran, Vernon T. Farewell, Cheryl F. Rosen, Dafna D. Gladman
The Journal of Rheumatology May 2015, 42 (5) 841-846; DOI: 10.3899/jrheum.140857